Radiation Dose Management Market worth 931.3 Million USD by 2022

According to the new market research report “Radiation Dose Management Market by Products & Services (Standalone, Integrated Solutions, Consulting Services), Application (Computed Tomography, Fluoroscopy, Mammography), End user (Hospitals, Ambulatory Care Settings) – Global Forecast to 2022”, published by MarketsandMarkets™, the global radiation dose management market was valued at USD 161.3 Million in 2017. This market is expected to grow at a CAGR of 42.0% during the forecast period (2017–2022) to reach USD 931.3 Million by 2022.
Don’t miss out on business opportunities in Radiation Dose Management Market. Speak to our analyst and gain crucial industry insights that will help your business grow:

http://bit.ly/2NXP0oD

The growing adoption of EHR systems, increasing initiatives for the implementation of health information exchanges (HIEs), growing awareness on radiation safety, increasing radiation exposure to patients, and increasing number of diagnostic imaging exams across the globe are other factors driving the growth of the market. However, the lack of in-house education and training on radiation dose management, lack of understanding amongst physicians and technologists towards dose optimization approaches, and low adoption of radiation dose management solutions in emerging countries are some of the factors restraining the growth of this market. 

Healthcare IT industry to account for largest size of industrial valve market from 2017 to 2023

However, the market in Europe is expected to grow at the highest CAGR during the forecast period. Government initiatives in this region to increase patient safety and the need to improve overall efficiency in healthcare organizations are driving the growth of the European market. The EU directives regarding the use of ionizing radiation, which will be repealed from February 6, 2018, is a prime factor for the increasing adoption of radiation dose management solutions by healthcare providers in Europe, which in turn is driving the growth of this geographic segment during the next two years.

Browse and in-depth TOC on ” Radiation Dose Management Market

117 – Tables

60 – Figures

193 – Pages 

View more detailed TOC @

http://bit.ly/2Iw39Uj

Radiation Dose Management Market for Increasing Concerns Over Radiation Overexposure to grow at high CAGR from 2018 to 2023

The global radiation dose management market is estimated to grow at a CAGR of 42.0% from 2017 to 2022, to reach USD 931.3 Million by 2022 from USD 161.3 Million in 2017. The growing adoption of EHR systems, increasing initiatives for the implementation of health information exchanges (HIEs), growing awareness on radiation safety, increasing radiation exposure to patients, and increasing number of diagnostic imaging exams across the globe are other factors driving the growth of the radiation dose management market. However, the lack of in-house education and training on radiation dose management, lack of understanding amongst physicians and technologists towards dose optimization approaches, and low adoption of radiation dose management solutions in emerging countries are some of the factors restraining the growth of this market.

North America is expected to hold largest share of Radiation Dose Management Market from 2017 to 2023

However, the market in Europe is expected to grow at the highest CAGR during the forecast period. Government initiatives in this region to increase patient safety and the need to improve overall efficiency in healthcare organizations are driving the growth of the European market. The EU directives regarding the use of ionizing radiation, which will be repealed from February 6, 2018, is a prime factor for the increasing adoption of radiation dose management solutions by healthcare providers in Europe, which in turn is driving the growth of this geographic segment during the next two years.

Request for Free Sample Report @ http://bit.ly/2xPffDx

Prominent players in this market are Bayer AG (Germany), GE Healthcare (U.S.), PACSHealth LLC (U.S.), Philips Healthcare (Netherlands), Fujifilm Holdings Corporation (Japan), Novarad Corporation (U.S.) Siemens Healthineers (Germany), AGFA Healthcare (Belgium), Sectra AB (Sweden), QAELUM N.V. (Belgium), Bracco Imaging S.p.A. (Italy), and Medsquare (France).
Browse Adjacent Markets @ Healthcare IT Reports & Consulting

Share this post:

Related Posts

Comments are closed.